Literature DB >> 22801833

Resolution of congenital nasolacrimal duct obstruction with nonsurgical management.

.   

Abstract

OBJECTIVE: To determine how often nasolacrimal duct obstruction (NLDO) resolves with 6 months of nonsurgical management in infants aged 6 to less than 10 months.
METHODS: As part of a randomized trial evaluating the cost-effectiveness of immediate office probing vs observation with deferred probing for unresolved cases, 107 infants aged 6 to less than 10 months who had NLDO and no history of nasolacrimal duct surgery were prescribed 6 months of nasolacrimal duct massage and topical antibiotics as needed. Resolution of the NLDO was assessed 6 months after study entry and was defined as the absence of all clinical signs of NLDO (epiphora, increased tear lake, or mucous discharge) and not having undergone NLDO surgery. Exploratory analyses assessed whether baseline characteristics, including age, sex, laterality, and prior treatment, were associated with the probability of NLDO resolving without surgery.
RESULTS: At the 6-month examination, which was completed for 117 of the 133 eyes (88%), the NLDO had resolved without surgery in 77 eyes (66% [95% CI, 56%-74%]). None of the baseline characteristics we evaluated were found to be associated with resolution.
CONCLUSIONS: In infants 6 to less than 10 months of age, more than half of eyes with NLDO will resolve within 6 months with nonsurgical management. Knowledge of the rate of NLDO resolution in infancy without surgery will help clinicians and parents effectively discuss treatment options.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801833      PMCID: PMC3409462          DOI: 10.1001/archophthalmol.2012.454

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  7 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  Dacryostenosis.

Authors:  H W PRICE
Journal:  J Pediatr       Date:  1947-03       Impact factor: 4.406

3.  Models for longitudinal data: a generalized estimating equation approach.

Authors:  S L Zeger; K Y Liang; P S Albert
Journal:  Biometrics       Date:  1988-12       Impact factor: 2.571

4.  Congenital nasolacrimal system obstruction.

Authors:  B J Kushner
Journal:  Arch Ophthalmol       Date:  1982-04

5.  Medical management of congenital nasolacrimal duct obstruction.

Authors:  L R Nelson; J H Calhoun; H Menduke
Journal:  Ophthalmology       Date:  1985-09       Impact factor: 12.079

6.  Medical management of congenital nasolacrimal duct obstruction.

Authors:  T O Paul
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1985 Mar-Apr       Impact factor: 1.402

7.  The natural course of congenital obstruction of the nasolacrimal duct.

Authors:  R A Petersen; R M Robb
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1978 Jul-Aug       Impact factor: 1.402

  7 in total
  18 in total

Review 1.  Probing for congenital nasolacrimal duct obstruction.

Authors:  Carisa Petris; Don Liu
Journal:  Cochrane Database Syst Rev       Date:  2017-07-12

2.  Office probing for treatment of nasolacrimal duct obstruction in infants.

Authors:  Aaron M Miller; Danielle L Chandler; Michael X Repka; Darren L Hoover; Katherine A Lee; Michele Melia; Paul J Rychwalski; David I Silbert; Roy W Beck; Eric R Crouch; Sean Donahue; Jonathan M Holmes; Graham E Quinn; Nick A Sala; Susan Schloff; David K Wallace; Nicole C Foster; Kevin D Frick; Richard P Golden; Scott R Lambert; D Robbins Tien; David R Weakley
Journal:  J AAPOS       Date:  2014-02       Impact factor: 1.220

3.  A comparison between monocanalicular and pushed monocanalicular silicone intubation in the treatment of congenital nasolacrimal duct obstruction.

Authors:  Dima Andalib; Hossein Mansoori
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

4.  Pediatric nasolacrimal duct obstruction-benefit of a combined therapeutic approach.

Authors:  Miloš Fischer; Iris-Susanne Horn; Mathias Otto; Mandy Pirlich; Andreas Dietz; Christian Mozet
Journal:  World J Pediatr       Date:  2017-05-24       Impact factor: 2.764

5.  Effects of medication methods after simple and effective probing of lacrimal passage.

Authors:  Bin Lu; Hua-Ying Xie; Cai-Ping Shi; Chun-Si Xu; Mei-Hong Gu
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

6.  Probing for congenital nasolacrimal duct obstruction in older children.

Authors:  Bahram Eshragi; Masoud Aghsaei Fard; Babak Masomian; Mohammadreza Akbari
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

7.  Lacrimal and nasal masquerades of congenital nasolacrimal duct obstructions: etiology, management, and outcomes.

Authors:  Saurabh Kamal; Mohammad Javed Ali; Adit Gupta; Milind N Naik
Journal:  Int Ophthalmol       Date:  2015-02-14       Impact factor: 2.031

8.  A comparison of treatment approaches for bilateral congenital nasolacrimal duct obstruction.

Authors:  Katherine A Lee; Danielle L Chandler; Michael X Repka; Michele Melia; Roy W Beck; C Gail Summers; Kevin D Frick; Nicole C Foster; Raymond T Kraker; Scott Atkinson
Journal:  Am J Ophthalmol       Date:  2013-08-15       Impact factor: 5.258

Review 9.  [Minimally invasive diagnostics and therapy of congenital nasolacrimal duct obstruction].

Authors:  J Heichel; H-G Struck
Journal:  Ophthalmologe       Date:  2017-05       Impact factor: 1.059

10.  Primary probing for congenital nasolacrimal duct obstruction with manually curved Bowman probes.

Authors:  Didem Serin; Ibrahim Bulent Buttanri; Mehmet Sahin Sevim; Bahtinur Buttanri
Journal:  Clin Ophthalmol       Date:  2013-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.